12/07/2007 12:00AM

Proud Tower Too injury leads to his retirement

EmailINGLEWOOD, Calif. - Proud Tower Too, the winner of the Grade 1 Malibu Stakes in 2005 and the $2 million Golden Shaheen Sprint in Dubai in 2006, has been retired because of a recurring tendon injury, trainer Sal Gonzalez said Friday.

Owned and bred by Daniel Cardenas's Tricar Stables, Proud Tower Too won 7 of 22 starts and $1,735,572. The 5-year-old horse was in training with Gonzalez at Sunland Park in New Mexico this fall when the injury was detected. Proud Tower Too finished second in the Grade 2 San Carlos Handicap in February in his final start.

The recent setback is a recurrence of a tendon injury first discovered in March. At the time, Gonzalez said that Proud Tower Too would need a six-month break.

"We put him back in training in September," Gonzalez said. "I worked him and he had a filling in the tendon. We decided to just stop on him.

"He gave us the most satisfaction from a racehorse. We're very grateful for him. He was a very good racehorse."

Gonzalez said that negotiations are taking place with a California farm for Proud Tower Too to stand at stud in 2008.

Barretts steroid ban expanded

The Barretts sales company, which announced earlier this week that it will ban anabolic steroids from sale yearlings and weanlings beginning with auctions in 2008, will implement a similar program for its popular 2-year-olds in-training sales in 2009, president and general manager Gerald McMahon said on Friday.

Barretts joins Keeneland, Fasig-Tipton, and Ocala Breeders' Sales as major auction companies that are banning the use of steroids in weanlings and yearlings within 45 days of a sale.

McMahon said that Barretts is working with officials from the California Horse Racing Board on details of the testing.

Racing board officials have said they hope to have a steroid ban in place for racehorses by July 2008, well before the Breeders' Cup is held in late October at Santa Anita's Oak Tree meeting.

The board in late November moved forward with a proposed rule to set threshold limits for four anabolic steroids - nandrolone, boldenone, testosterone, and stanozolol - which will be tested from urine samples.

The 2-year-old sales at Barretts will comply with those rules at the 2009 in-training sales, the first held after the rules go into effect, McMahon said.

"Right now, our plan is to move forward as racing moves forward," McMahon said.

At the recent racing board meeting, chairman Richard Shapiro called for a ban of the use of steroids at 2-year-old in-training sales.

"As quickly as possible, we need to extend the restrictions to the 2-year-olds in-training sales, so that horses being sold are under racetrack conditions and scrutiny," he said. "Buyers can have confidence that horses are being sold with the highest level of integrity."

The use of anabolic steroids in yearlings and weanlings "is not a major issue in California," McMahon said. "In the national context, this is something that everyone is moving forward on and we want to be part of that."

McMahon said the first Barretts sales that will be affected by the steroid rule is the 2008 California October yearling sale.

Barretts has moved the dates of its sales in January and March to accommodate a revamped racing schedule at Santa Anita that includes Monday racing.

The January mixed sale, originally scheduled for Jan. 21 and 22, will be conducted on Jan. 22 and 23.

The March sale of 2-year-olds in-training has been pushed back one day from March 11 to March 12. The sale preview days will be March 4 and 10.